1 / 12

Open & consultative process

Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System Helen Stevenson Executive Lead, Drug System Secretariat Ministry of Health and Long-Term Care. Open & consultative process. Drug System Secretariat established in June 2005 to lead system-wide review

carney
Télécharger la présentation

Open & consultative process

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Right Drug, Right Person, Right Price:Improving and Governing the Provincial Drug SystemHelen StevensonExecutive Lead, Drug System SecretariatMinistry of Health and Long-Term Care

  2. Open & consultative process Drug System Secretariat established in June 2005 to lead system-wide review Phase 1: Research • 250+ experts consulted • 2 jurisdictions visited – UK and US Phase 2: Consultation • 105 meetings with 350+ people over 6 weeks • 92 written submissions received – 1,000+ pages • Consumer and patient roundtable • Public opinion focus groups in 5 centres across Ontario Stakeholders included • Patients; patient and/or disease groups; Consumer advocacy groups • Physicians; Family Health Teams • Pharmacists (community & hospital-based); pharmacies • Specialized agencies (CCO); Hospitals • Manufacturers; wholesalers • Professional associations; industry associations • Major employers; private insurers • Other ministries • Public

  3. Context for Action • Patients need better and faster access to drugs • The public needs a voice in the system • Government could get better value for money • Government does not leverage its $3.5 billion purchasing power • Need for collaboration with private sector to help employers manage drug costs and remain economically competitive in Ontario

  4. Recommendations: Five Key Areas • Improving access for patients to drugs • Strengthening our position as a customer to get value-for-money • Promoting appropriate use of drugs • Rewarding innovation • Strengthening the governance and operations of the public drug system Status: • Government gave direction to move forward on entire package • Legislative changes in Bill 102, Transparent Drug System for Patients Act • Regulation changes intended to be brought forward shortly for consultation • Where policy recommendations, approval to move forward • Referred to Standing Committee on Social Policy; public hearings May 29, 30, June 5 followed by clause-by-clause review June 6, 2006 • Bill amended by Committee adopted June 7; Bill awaiting Third Reading

  5. Improving access for patients to drugs

  6. Improving access for patients to drugs

  7. Strengthening our position as a customer to get value-for-money

  8. Strengthening our position as a customer to get value-for-money

  9. Strengthening our position as a customer to get value-for-money

  10. Promoting appropriate use of drugs Rewarding innovation

  11. Strengthening the governance and operations of the public drug system

  12. Strengthening the governance and operations of the public drug system

More Related